Whoop Names CMO as Consumer Wearables Push for Clinical Legitimacy

References

1. 1.Aguilar, M. (2026, July 28). Three questions with Whoop's new CMO. STAT News. https://www.statnews.com/2026/07/28/three-questions-with-whoops-new-cmo-health-tech/
2. 2.Coravos, A., Khozin, S., & Mandl, K. D. (2019). Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digital Medicine, 2(1), 14. https://doi.org/10.1038/s41746-019-0090-4
3. 3.Dunn, J., Runge, R., & Snyder, M. (2018). Wearables and the medical revolution. Personalized Medicine, 15(5), 429–448. https://doi.org/10.2217/pme-2017-0062
4. 4.Düking, P., Hotho, A., Holmberg, H.-C., Fuss, F. K., & Sperlich, B. (2016). Comparison of non-invasive individual monitoring of the training and health of athletes with commercially available wearable technologies. Frontiers in Physiology, 7, 71. https://doi.org/10.3389/fphys.2016.00071
5. 5.Meskó, B., & Topol, E. J. (2023). The imperative for regulatory oversight of large language models (or generative AI) in healthcare. npj Digital Medicine, 6(1), 120. https://doi.org/10.1038/s41746-023-00873-0
6. 6.Office of the Australian Information Commissioner. (2023). Privacy Act 1988: Health information and privacy. Australian Government. https://www.oaic.gov.au/privacy/the-privacy-act/health-information-and-privacy
7. 7.Steinhubl, S. R., Muse, E. D., & Topol, E. J. (2015). The emerging field of mobile health. Science Translational Medicine, 7(283), 283rv3. https://doi.org/10.1126/scitranslmed.aaa3487
8. 8.Therapeutic Goods Administration. (2023). Software as a medical device (SaMD): Key concepts. Australian Government Department of Health and Aged Care. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-samd-key-concepts